SHL Telemedicine announces it is exploring dual listing on another leading Stock Exchange in the US or on the Tel Aviv Stock Exchange

Tel Aviv / Zurich, 22 February 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL” or “the company”), a leading provider and developer of advanced personal telemedicine solutions, announced today that the company has begun exploring the possibility of dual-listing for trading on another stock exchange. The alternatives being considered by SHL include listing on a leading US stock exchange, one of the company’s main target markets, as well as on the Tel Aviv Stock Exchange.